Targeting Toll-like receptor 4 inflammatory pathways and renin-angiotensin system signaling to reduce myocardial fibrosis and abnormal cardiac remodeling following preterm birth warrants further investigation in humans. This evidence concerns the gene TLR4 and Myocardial fibrosis.